New updates have been launched by the ACMD (Advisory Council on the Misuse of Drugs) in relation to reducing the barriers to research using compounds described by the third generation synthetic cannabinoid receptor agonists generic definition.
The ACMD (Advisory Council on the Advisory Council on the Misuse of Drugs) and MHRA (Medicines & Healthcare products
Regulatory Agency) has evaluated the risk of substance abuse and physical dependency of the medicine Sunosi (Solriamfetol). Sunosi is a once-daily prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness due to obstructive sleep apnoea or narcolepsy.
Find out all you need to know and more in our article on the subject here!…
The UK Government’s Advisory Council For The Misuse Of Drugs Committee is looking at barriers to research working group calls for written evidence about barriers to legitimate research for controlled drugs.
We all need to do our part to advance the knowledge, care pathways, treatment options and improvement for the statistical improvement on the chances for long term, successful, happy, healthy recovery.